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Annese et al. find that neural-crest-
derived stem cells residing in the adult
carotid body are multipotent. These cells
have the capacity to contribute to both
neurogenesis and angiogenesis during
organ acclimatization to hypoxia.
Endothelial fate specification is achieved
by intrinsic (HIF2a) and extrinsic (EPO)
mechanisms.
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Adult stem cell plasticity, or the ability of somatic
stem cells to cross boundaries and differentiate
into unrelated cell types, has been amatter of debate
in the last decade. Neural-crest-derived stem cells
(NCSCs) display a remarkable plasticity during
development. Whether adult populations of NCSCs
retain this plasticity is largely unknown. Herein, we
describe that neural-crest-derived adult carotid
body stem cells (CBSCs) are able to undergo endo-
thelial differentiation in addition to their reported
role in neurogenesis, contributing to both neurogenic
and angiogenic processes taking place in the organ
during acclimatization to hypoxia. Moreover, CBSC
conversion into vascular cell types is hypoxia induc-
ible factor (HIF) dependent and sensitive to hypoxia-
released vascular cytokines such as erythropoietin.
Our data highlight a remarkable physiological plas-
ticity in an adult population of tissue-specific stem
cells and could have impact on the use of these cells
for cell therapy.INTRODUCTION
The carotid body (CB), a neural-crest-derived paired organ
located in the carotid bifurcation, is the main arterial chemore-
ceptor in mammals and facilitates reflex hyperventilation during
hypoxia (Lo´pez-Barneo et al., 2001). In addition, the CB is able to
undergo neurogenesis to contribute to acclimatization of the or-
ganism during a persistent hypoxia (Edwards et al., 1971; Arias-
Stella and Valcarcel, 1976; Heath et al., 1982;Wang andBisgard,
2002). We have previously shown that glia-like sustentacular, or
type II, cells surrounding chemosensory neuron-like glomus cells
are neural crest stem cells (NCSCs) and contribute to CB growth
in hypoxia by differentiating into new glomus cells (Pardal et al.,
2007; Platero-Luengo et al., 2014). In addition to this neurogenic
activity, a profound angiogenic process takes place in the hyp-
oxic CB (Wang and Bisgard, 2002; Chen et al., 2007a). Whether
neural-crest-derived adult CB stem cells (CBSCs) are able to
differentiate into vascular cells, contributing to angiogenesis
in vivo, in addition to neurogenesis, is largely unknown. WeC
This is an open access article under the CC BY-Nhave recently described the presence of mesectoderm-
restricted progenitors within CB parenchyma and have shown
that these cells are able to convert into endothelial cells in vitro
(Navarro-Guerrero et al., 2016). Therefore, the CB constitutes
an ideal model where to study the potential plasticity of an adult
population of NCSCs.
Utilizing both in vitro assays and in vivo cell-fate mapping ex-
periments, we show that adult CBSCs do indeed retain multipo-
tent differentiation capacity, being able to convert into endothe-
lial cells (ECs) contributing to hypoxia-induced angiogenesis
during acclimatization of the organ. Moreover, we providemech-
anistic insight into this process by showing that CBSCs differen-
tiate into ECs via a hypoxia inducible factor (HIF)-dependent
mechanism and in response to hypoxia-released molecules
such as erythropoietin. Thus, CBSCs use plasticity to facilitate
physiological adaptation of the CB, and hence the organism, to
hypoxia.RESULTS
CBSCs Differentiate Into Vascular Cell Types under
Hypoxic Conditions
In order to test the ability of CBSCs to contribute to vascular cell
types, we decided to perform in vivo cell-fate mapping using
GFAP-cre/floxed LacZ or YFP transgenic mice. These animals
express the b-galactosidase enzyme (b-gal), or the yellow fluo-
rescent protein (YFP), in GFAP+ CBSCs and their derivatives
(Pardal et al., 2007). However, the human GFAP promoter in
this type of construct is not expressed in all GFAP+ mouse cells,
as previously revealed in brain astrocytes (Malatesta et al.,
2003). In the case of CB, a first exposure to hypoxia (7 days; Fig-
ure S1) needs to be performed in order to activate the construct
(Pardal et al., 2007), and only around 50% of GFAP+ CBSCs get
labeled (Figure S1F). After this first exposure to hypoxia, only
GFAP+ CB stem cells and their derivatives in resting conditions,
i.e., some nestin+ progenitor cells, appear labeled (Figures S1G
and S1H), confirming the specificity of the construct. After
construct activation, we exposed GFAP-cre/floxed LacZ mice
to hypoxia for 7 days (for hypoxic stimulus confirmation, see Fig-
ures 4K and S5C) and interrogated vascular cells for the expres-
sion of LacZ. By using an antibody against b-gal, and GSA I, an
endothelium-specific lectin, we found that 16.3% ± 2.7% of ECs
were positive for b-gal (39 out of 229 GSA I+ cells analyzed; Fig-
ures 1A and S1J). No single b-gal+ GSA I+ cell was found in theell Reports 19, 471–478, April 18, 2017 ª 2017 The Author(s). 471
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. CB Stem Cells Contribute to
Angiogenesis in Addition to Neurogenesis
under Hypoxia
(A) Z stack projection picture obtained by confocal
microscopy from a CB section of a hypoxic GFAP-
cre/floxed LacZ mouse, immunostained with an
antibody against b-galactosidase (red) and stained
with the endothelial marker GSA I (green). ECs
derived from GFAP+ type II cells are shown in the
enlargements of the boxed areas (arrows). Scale
bars, 10 mm. Confocal pictures were taken in sec-
tions from two animals per group.
(B–E) Examples of X-gal+ cells dispersed from the
CB of hypoxic GFAP-cre/floxed LacZ mice. The
pictures illustrate the appearance of X-gal+ ECs
(GSA I+, B), glomus cells (TH+, C), smooth muscle
cells (SMA+, D), and pericytes (NG2+, E). Scale
bars, 5 mm. n = 3 independent experiments.
(F) Fluorescence confocal microscopy pictures of
CB sections from hypoxic GFAP-cre/floxed YFP
mouse stained with anti-YFP antibody (green) and
rodhamine-conjugated GSA I lectin. Arrows point
to double-positive vessels. A higher magnification
of the boxed region depicted in (F), showing z axis
projection views, is shown in (1). Scale bars, 25 mm.
n = 3 animals per experimental group.
(G) Picture of ex vivo hypoxic CB preparation
stained with GSA I (green) and immunolabeled
with an antibody against YFP reporter protein (red).
Note the presence of GSA I positive ECs, negative
for the reporter protein (white arrowheads). Scale
bar, 25 mm.
(H and I) Examples of GFAP+ cell-derived CD31+
ECs, found in CB cell dispersions from bothGFAP-
cre/floxed YFP (H) and GFAP-cre/floxed LacZ (I)
mice. Scale bars, 20 mm.
See also Figures S1 and S2.CBs of normoxic GFAP-cre/floxed LacZ littermate mice (99
GSA I+ cells analyzed), a result that was confirmed with YFP
transgenic mice (Figure S1D). Differentiation of GFAP+ CBSCs
into ECs was confirmed in CB dispersed cells from hypoxic
GFAP-cre/floxed LacZ mice, by using classical X-gal staining
to reveal the activity of b-gal, and fluorescent cytochemistry to
detect GSA I (Figure 1B), or the endothelial markers CD31 (Fig-
ure 1I), or von Willebrand factor (vWF; Figures S1K and S1L).
Moreover, by using this CB ex vivo preparation, we confirmed
neuronal differentiation capacity of GFAP+ CBSCs in the same472 Cell Reports 19, 471–478, April 18, 2017mice (Figure 1C). Interestingly, by using
a smooth muscle cell marker (SMA;
Figure 1D) and a pericyte marker (NG2;
Figure 1E), we also uncovered the ability
of CB neural progenitors to convert into
other mesenchymal cell types forming
the vascular compartment, suggesting
that CB progenitors can give rise to com-
plete blood vessels. The use of a second
type of reporter mouse strain (GFAP-cre/
floxed YFP mice) corroborated the cell-
fate mapping results, both at the immu-
nochemical (Figures 1F–1H) and flowcytometry (fluorescence-activated cell sorting [FACS]; Fig-
ure S1I) levels. The percentage of YFP+ GSA I+ cells, obtained
from GFAP-cre/floxed YFP mouse CBs, was smaller (9.31% ±
0.59%) than from the LacZmouse model, probably due to differ-
ences in Cre-mediated excision efficiencies between the two re-
porter genes used. The use of a different EC marker, such as
CD31, for cell-fate mapping (Figures 1H, 1I, and S1I) yielded
qualitatively very similar results. No single EC, labeled with the
reporter gene, was found when analyzing the CB of TH-Cre/
floxed LacZ mice (Figure S1M), ruling out an unspecific
Figure 2. Single Progenitor Cells Display
Multipotency In Vitro
(A and C) Bright-field photographs of secondary
NS formed from single progenitors derived from
enzymatic dispersion of primary NS. Scale bars,
5 mm.
(B and D) Immunofluorescence pictures of
adherent secondary NS obtained from a single
NS-derived progenitor cell (NSPC). Combinations
of different cellular markers were tested inside the
same colony (Tuj1 [green] and GSA I [red] in B, and
TH [green] and vWF [red] in D). Scale bars, 100 mm.
B1 and B2 and D1 and D2 show high-magnification
images of the areas boxed in (B) and (D). Scale
bars, 10 mm, in B1 andB2, and 30 mm, in D1 andD2.
n = 4 primary NS cultures.
(E) Flow cytometry plot of dispersed rat CB cells
transfected with pGFAP-eGFP plasmid.
(F) Image representing GFAP+ cell enrichment in
GFP+ cell population sorted out by flow cytometry.
Scale bar, 10 mm.
(G) Bright-field pictures showing the ability of
single-cell plated GFP+ cells (1 d) to form NS after
15 days (15 d) in culture. Scale bars, upper panel
10 mm and bottom panel 50 mm.
(H) Example of a single-cell-derived NS, containing
cells of both neuronal (TH, red) and endothelial
(GSA I, green) lineages. Scale bars, 10 mm, in (H),
and 5 mm, in inset.
(I) Single-cell plating experiment performed using
dispersed CB cells from hGFAP-GFPmice. Picture
shows an example NS, double positive for neuronal
(TH, green) and endothelial (GSA I, red) markers.
Scale bar, 50 mm.
See also Figure S3.expression of Cre recombinase by ECs, and confirming the dif-
ferentiation of GFAP+ CBSCs into vascular cells.
We corroborated the multipotent differentiation capacity of
CBSCs in vivo, by performing bluo-gal staining and electron mi-
croscopy (EM) on the CB of hypoxicGFAP-cre/floxed LacZmice
(see Figure S2 and its legend). Altogether, in vivo cell-fate map-
ping experiments identify CBSCs as multipotent neural-crest-
derived adult stem cells contributing to both neurogenesis and
angiogenesis during hypoxic acclimatization of the organ.
Single CBSCs Display Multipotentiality In Vitro
To directly prove the multipotential capacity of CBSCs to differ-
entiate into both neuronal and vascular cell types, we performedCsingle-cell deposition experiments in vitro
(Figure 2). Out of 1,536 dispersed primary
neurosphere (NS) cells plated, 200 of
them gave rise to secondary NS. Upon
plating onto adherent conditions, 15 of
those NS (7.5%) contained both neuronal
and mesectodermal cells within the col-
ony (Figures 2A–2D and S3A–S3F), con-
firming differentiation into both cell line-
ages from a single progenitor cell. The
percentage of multipotent progenitor cells
is likely being underestimated due to thelack of appropriate neuronal differentiation conditions in the sin-
gle-cell plating assay. In addition to Tuj1 and GSA I markers (Fig-
ure 2B), we have corroborated the presence of neuronal and
mesectodermal cells with different widely usedmarkers: tyrosine
hydroxylase (TH) for dopaminergic neuronal cells and vWF, NG2,
and CD34 for vascular cells (Figures 2D and S3). We also per-
formed single-cell plating analysis with FACS-sorted rat CB cells
previously transfected with a pGFAP-eGFP construct, where
100% of GFP+-sorted cells were GFAP+ CBSCs (Figures 2E
and 2F). Although the frequencies of NS formation and neuronal
differentiation were quite low, likely due to transfection- and
FACS-induced damage, and lack of optimal neuronal differenti-
ation conditions, we were able to find some examples ofell Reports 19, 471–478, April 18, 2017 473
Figure 3. Vascular Factors Increase CBSC
Endothelial Differentiation In Vitro
(A) Epifluorescent detection of GSA I (ECs; red) in
adherent NS cultured on fibronectin in standard
neural crest culture medium without mitogens
(CTRL) and supplemented with vascular or
neuronal factors. Scale bar, 200 mm.
(B) Quantification graph indicating the mean per-
centage of GSA I+ cells among total cells in
different culture conditions. Data are represented
as the mean ± SEM.; *p% 0.05, **p% 0.01; # p%
0.001, one-way ANOVA Newman-Keuls post hoc
test compared to CTRL measurement. n = from
three to nine independent NS cultures.
(C and D) Graphs representing a significant in-
crease in mRNA expression of two classical hyp-
oxia-inducible genes, VEGF (C) and GLUT1 (D). n =
4 independent NS cultures. In vitro hypoxia ex-
periments were performed at 3% O2. Data are
represented as mean ± SEM.
(E) RT-PCRs revealing expression of mature
endothelial markers in rat liver and in GSA I+ cells
isolated fromCBor adherent NS by flow cytometry.
(F) Agarose gel showing THmRNA amplified by RT-
PCR in GSA - cell fraction isolated from adherent
NS. Three independent RNA extractions were
tested for each gene expression analysis.
(G) Binding of FITC-GSA I and uptake of DiI-acet-
ylated LDL (Ac-LDL) in ECs in vitro, visualized by
fluorescence microscopy. Nuclei are counter-
stained with DAPI (blue). Scale bars, 50 mm (top)
and 25 mm (bottom). n = 3 NS cultures.
See also Figures S3, S4, and S6.multipotent differentiation from single CBSCs (Figures 2G and
2H). Consistently, we also found multipotent differentiation
when plating single GFP+ cells from CBs of GFAP-eGFP trans-
genic mice (Figure 2I). Altogether, our single-cell plating data
confirm multipotent differentiation capacity in CBSCs.
CBSCs Are Sensitive to Vascular Factors and
Differentiate into Functional ECs
We next decided to explore the mechanisms by which CBSCs
differentiate into ECs by using in vitro assays and rat CB cells,
since the organ in rats is more manageable than in mice and
the cells grow better in culture. Rat CBSC-derived NS can474 Cell Reports 19, 471–478, April 18, 2017be plated onto adherent conditions
where, upon mitogen withdrawal, cells
are induced to differentiate. Using this
assay, we found that CB progenitors
differentiate into ECs (GSA I+) when
exposed to adherent substrate (control
in Figures 3A and 3B). However, this
differentiation was dramatically enhanced
when the cells were exposed to hypoxia
(see Figures 3C and 3D for hypoxia
confirmation in vitro) or vascular factors
(Figures 3A and 3B), such as erythropoi-
etin (EPO), endothelin-1 (ET-1), platelet-
derived growth factor (PDGF), vascularendothelial growth factor (VEGF), or adenosine (ADO). This differ-
entiation effect appeared to be specific for vascular factors since
the addition of typical CB neuronal factors, such as dopamine
(DA) or methionine-enkephalin (Met-Enk) (Gonza´lez-Guerrero
et al., 1993; Gauda and Gerfen, 1996), did not increase endothe-
lial differentiation (Figures 3A and 3B). Interestingly, most
vascular factors studied are consistently expressed in CB ECs,
as assessed by RT-PCR on FACS-sorted CB cells (Figure S3H).
We next evaluated the expression of mature EC markers in
GSA I+ NS cells, using GSA I+ CB dispersed cells and liver cells
as positive controls (Figure 3E). We confirmed the expression of
vWF, endothelial NO synthase (eNOS), and cadherin V, all of
them specific for mature endothelium. We also confirmed the
expression of the receptors for the different vascular factors
that activate endothelial differentiation in CBSCs (Figure S3I).
Both CB- and NS-derived GSA I+ cells lack expression of the re-
ceptor for DA (DRD2; Figure S3J), a neurotransmitter that did not
increase endothelial differentiation (Figures 3A and 3B). As a
control, we tested the expression of a CB neuronal marker (TH;
Figure 3F), corroborating the lack of neuronal cell contamination
in GSA I+ populations. Moreover, we studied the functionality of
CBSC-derived ECs obtained in vitro, by performing a low-den-
sity lipoprotein (LDL) uptake assay (Voyta et al., 1984). Out of
216 GSA I+ cells analyzed from three independent cultures,
95% ± 1.5% of them were also positive for DiI-conjugated Ac-
LDL (Figure 3G), confirming the uptake and intracellular storage
of lipoproteins, and hence the functionality of ECs differentiated
from CBSCs in vitro. Finally, we decided to confirm the vasculo-
genic capacity of CB progenitor cells by using Matrigel and a
subcutaneous vasculogenesis assay (see Figure S4). Taken
together, in vitro and in vivo functional assays and endothelial
marker expression analysis indicate that neural-crest-derived
CBSCs are able to differentiate into mature and functional ECs,
supporting their capacity to participate in CB angiogenesis.
Endothelial Differentiation from CBSCs Is HIF
Dependent and Sensitive to EPO
Interestingly, in vitro differentiation assays indicate that CBSC
conversion into ECs is directly favored by low oxygen (see Fig-
ure 3A). Therefore, we decided to check whether CBSCs were
intrinsically sensitive to hypoxia, and whether prolyl hydroxylase
(PHD)/HIF pathway had a role in the vascular differentiation pro-
cess. Our data (see Figure S5) clearly establish an important,
although partial, role for HIF2a in the endothelial differentiation
process. In addition, we decided to further study the role of a
relevant hypoxia-induced vascular cytokine, EPO. EPO is a he-
matopoietic factor, finely regulated by oxygen tension (Franke
et al., 2013), that has been described to participate in angiogen-
esis (Heeschen et al., 2003). In vitro results described above
show that EPO increases the number of ECs obtained from
CBSCs (see Figures 3A and 3B), and this is achieved without
affecting neuronal differentiation (Figures 4A and 4B). Moreover,
EPO receptor (EPOR) is expressed by both NS- and CB-derived
nestin+-activated progenitors (Figure 4C), suggesting a direct
role of this cytokine on CBSC fate determination. Therefore,
we decided to further examine the role of EPO on CB angiogen-
esis both in vitro and in vivo. The addition to adherent NS
cultures of an antibody against EPO, that sequesters the he-
matopoietic cytokine, completely abrogated the increase in
endothelial differentiation (Figures 4D and 4E). AG490 is an inhib-
itor of EPOR-associated Janus kinase (Jak) 2 that has been
described to block EPO intracellular signaling (Lester et al.,
2005). Addition of AG490 to EPO-treated adherent NS provoked
a significant decrease in the number of ECs obtained (Figures 4D
and 4E). Thus, our results suggest a specific role for EPO in the
induction of endothelial differentiation from CBSCs in vitro.
We then decided to corroborate that EPO was being endoge-
nously produced in theCB (Lamet al., 2009). As assessed byRT-
PCR, CB cells produce EPO especially in hypoxic conditions
(Figure 4F). In order to test whether cell-released EPO wasable to direct vascular differentiation from CB progenitors, we
performed hypoxic co-cultures of NS progenitor cells and ECs
(Figure 4G). For these co-culture experiments, we used a well-
characterized human EC line (HUVEC), which produces EPO
(Figure 4H). The presence of HUVECs in the surrounding wells
increased the amount of functional ECs in CB NS, an effect
that was abrogated after the addition of a blocking antibody
against EPO (Figures 4I and 4J), further corroborating the role
of EPO on CB progenitor endothelial differentiation in vitro.
Finally, we wanted to test whether EPO was having a relevant
role in hypoxia-induced CB angiogenesis in vivo. To this end,
we used GFAP-cre/floxed LacZ transgenic mice exposed to
hypoxia. Systemic injection of EPO signaling blocker AG490 in
these mice significantly attenuated the typical hypoxia-induced
EPO-mediated hematocrit increase (Figure 4K), corroborating
the systemic action of the inhibitor. CBSC-derived newly formed
ECs are labeled by b-galactosidase expression and hence
appear with blue precipitate after X-gal staining (Figure 4L).
Quantification of X-gal+ cells in dispersed CB of these AG490-
treated hypoxic mice revealed a decrease in the number of
GSA I+ ECs derived from CBSCs (Figure 4M), confirming the
importance of EPO release and EPO signaling in CBSC-depen-
dent angiogenesis.
DISCUSSION
In the present study, we show that adult CBSCs display multipo-
tent differentiation capacity, giving rise to both neural and non-
neural derivatives during physiological acclimatization of CB to
hypoxia. Our results show that around 10%–15% of total ECs,
after a single exposure of the organ to chronic hypoxia, are
derived from CBSCs, and this value is likely being underesti-
mated due to inefficient expression of transgenic constructs
(Figure S1). Considering that ECs are described to double their
number in the organ in response to hypoxia (Chen et al.,
2007a), we therefore estimate that around one every three or
four newly formed ECs is CBSC derived.
The ability of NSCs to differentiate into ECs has been previ-
ously described only in some in vitro studies (Wurmser et al.,
2004; Ii et al., 2009) or in the context of nervous system oncolog-
ical disease (Ricci-Vitiani et al., 2010; Wang et al., 2010; Pezzolo
et al., 2011; Cheng et al., 2013). However, to the best of our
knowledge, no other example has been reported about adult
neural progenitors participating in a physiological process of
angiogenesis in vivo.
In addition to the direct effect of hypoxia (see the role of HIF2a
in the Supplemental Information), conversion of CBSCs into ECs
is also clearly enhanced by the exposition of cells to vascular fac-
tors, which are particularly released during hypoxia (Fandrey,
1995). Among these factors, EPO has been described to regulate
CNS progenitor behavior (Shingo et al., 2001; Chen et al., 2007b)
and has a clear role enhancing vasculogenesis (Bahlmann et al.,
2004; Wang et al., 2004). Our results show that CB cells produce
this vascular factor mainly during hypoxia, indicating that locally
produced EPO might play a role in angiogenesis in the CB. This
result is consistent with the described production of EPO by
neuronal glomus cells in the organ (Lam et al., 2009). Moreover,
we have recently described a role for CB neuronal cells on theCell Reports 19, 471–478, April 18, 2017 475
Figure 4. EPO Promotes the Endothelial Dif-
ferentiation Capacity of CBSCs
(A) Immunohistochemistry pictures illustrating the
size of TH+ neuronal blebs in control and EPO-
exposed NS. Scale bar, 50 mm.
(B) Quantification of the percentage of TH+ cells
versus total cells in NS sections, comparing control
and EPO-treated NS. Data are represented as
the mean ± SEM. No statistical differences were
detected by Student’s t test.
(C) Immunofluorescence pictures showing pres-
ence of EPO receptor (EPOR) on the surface of
nestin+ progenitors in both NS (upper panels) and
CB (lower panels) tissues. Scale bars, 50 mm, in
upper panels, and 10 mm, in lower panels.
(D) Images displaying EC differentiation within
adherent cultures of primary NS in presence of
EPO, EPO combined with EPO neutralizing anti-
body, or EPOR inhibitor (AG490). Scale bar, 50 mm.
(E) Quantification graph indicating the mean
percentage of GSA I+ cells in different culture
conditions. Data are represented as the mean ±
SEM; *p % 0.05, one-way ANOVA Newman-
Keuls post hoc test compared to control mea-
surement (white bar), and #p % 0.05, one-way
ANOVA Newman-Keuls post hoc test compared
to EPO treated measurement (black bar) (n = 3
cultures).
(F) Agarose gel showing the presence of EPO
mRNA in hypoxic CB samples. n = 3.
(G) Schematic diagram describing the co-culture
experiment.
(H) Representative western blot detecting EPO in
three different hypoxic HUVEC protein extracts.
The antibody recognizes in the cell extracts a band
of about 38 kDa in concordance with human re-
combinant EPO (Hu-EPO).
(I) Pictures showing EC differentiation, detected
by intracellular DiI-Ac-LDL uptake, occurring in
NSPCs in different co-culture conditions. Parallel
NS cultures without HUVECs served as control
(CTRL). Scale bar, 25 mm.
(J) Quantification graph showing the percentage of
DiI-Ac-LDL+ cells detected in different co-culture
conditions. Data are represented as the mean ±
SEM.; **p % 0.01, one-way ANOVA Newman-
Keuls post hoc test compared to Ctrl measure-
ment; #p% 0.05, one-way ANOVA Newman-Keuls
post hoc test compared to HUVEC co-culture
measurement (n = 4 cultures).
(K) Histogram representing the significant increase
of hematocrit, a typical hypoxia-sensitive EPO-
mediated physiological variable, in experimental hypoxic animals (gray bar, n = 5) versus normoxic animals (white bar, n = 4). Consistently, treatment of hypoxic
animals with EPOR inhibitor AG490 produced a significant decrease of hematocrit levels (black bar) when compared to hypoxia. In vivo experiments were carried
out at 10% O2. Data are represented as mean ± SEM.
(L) Representative microphotographs of X-gal+ GSA I+ cells observed in dispersed CB from GFAP Cre/floxed LacZ mice exposed to hypoxia for 7 days. Scale
bars, 10 mm.
(M) Quantification of the percentage of X-gal+ GSA I+ cells versus total X-gal+ cells found in dissociated CBs from GFAP Cre/floxed LacZ mice injected with
vehicle (n = 3) or AG490 (n = 3), after 7 days of hypoxic treatment. **p% 0.01, Student’s t test compared to vehicle-treated hypoxic animals. Data are represented
as mean ± SEM.
See also Figures S5 and S6.proliferative activation of CBSCs through a different cytokine,
ET-1 (Platero-Luengo et al., 2014). The additional release of
EPO by CB glomus cells might represent another example of
neuronal activity-dependent regulation of stem cell behavior, in476 Cell Reports 19, 471–478, April 18, 2017this case promoting progenitors to participate in angiogenesis.
Nevertheless, we cannot formally discard an additional role for
circulating EPO in CB angiogenesis. Altogether, our results sug-
gest that CBSCs retain mesectodermal differentiation potential,
resembling neural progenitors in the peripheral nervous system
during development (Le Douarin et al., 2008). This ability allows
them to participate in physiological angiogenesis, in addition to
neurogenesis, during adaptation of the organ to hypoxia. This
finding might be relevant to understand the pathophysiology of
this chemoreceptor organ and to improve the therapeutic use
of these stem cells.
EXPERIMENTAL PROCEDURES
Animals
Male and female transgenic mice (4–6 weeks old or 8–9 months old for dime-
thyloxalylglycine [DMOG] in vivo experiments) and Wistar rats (6 weeks old)
were housed and treated according to the animal care guidelines of the Euro-
pean Community Council (86/609/EEC). All experimental procedures were
approved by the Committee on Animal Research at the University of Seville.
Details about the hypoxic treatment and drug administration are given in the
Supplemental Information.
Dissociation of CB Cells and NS Cultures
Rat and transgenic mouse CBs were dissociated by enzymatic treatment and
cultured to form NS, following protocols previously described (Pardal et al.,
2007). Specific details are given in the Supplemental Information.
Immunocytochemistry and Immunohistochemistry
Immunostainings were performed following standard procedures described
elsewhere (Pardal et al., 2007). Antibodies used are listed in Table S1. Specific
details about the immunostaining protocols are given in the Supplemental
Information.
X-Gal Staining
Dispersed CB cells from GFAP-cre/floxed LacZ and TH-cre/floxed LacZ mice
were plated in ultralow binding Petri dishes and allowed to recover superficial
epitopes, lost upon enzymatic dispersion, in an incubator overnight. After that,
standard protocols for X-gal staining were applied, as previously described
(Pardal et al., 2007). Once X-gal staining was performed, we processed the
cells for antibody staining as indicated previously.
EM
Carotid bifurcations were embedded in gelatin (80–100 bloom; Panreac)
supplemented with 2% glutaraldehyde (Electron Microscopy Sciences), and
50-mm-thick slices were cut on a vibratome (VT1000S; Leica Microsystems).
CB vibratome sections were processed for bluo-gal staining. Specific details
about this staining are given in the Supplemental Information.
In Vitro Multipotency Assay
Primary NS were collected in 15-mL conical tubes and centrifuged at 1003 g
for 1 min. Following aspiration of supernatant, NS were dispersed by Accutase
(Sigma), gently pipetting up and down during 10 min. After enzymatic treat-
ment, 4 mL of medium was added to quench enzymes. Dissociated NS cells
were centrifuged for 5 min at 300 3 g at 4C. Afterward, cells were resus-
pended and cultured at clonal density on an ultralow binding 96-well plate.
Secondary NS were re-plated onto adherent conditions using fibronectin
pre-treated plates, as described before. After 3 days in culture, adherent NS
colonies were fixed in 4% paraformaldehyde (PFA) and processed for immu-
nolabeling and GSA I staining (see above).
Endothelial Differentiation Assay
NS obtained from dispersed rat CBs were re-plated onto adherent conditions
using 5 mg/mL fibronectin (Biomedical Technologies) pre-treated 24-well
plates, at a density of 4 or 5 NS/well. Drug treatments are described in the Sup-
plemental Information. After growing for 3 days in adherent conditions, flat NS
colonies were fixed and stained with rodhamine or fluorescein-conjugated
GSA I (see Immunocytochemistry section). ImageJ software (National Institute
of Health) was used for cell number quantifications.RT-PCR and Real-Time qPCR
Total RNA was extracted from GSA I positive and negative cell fractions from
dispersed adherent NS or dispersed rat CBs, using a commercial kit (RNeasy
MICRO kit; QIAGEN), following manufacturer’s instructions. For retrotranscrip-
tion, cDNAwas synthesizedwithQuantiTecReverse transcription kit (QIAGEN),
as indicated by manufacturer’s instructions. Primer sequences are reported in
Table S2. Original gels for all PCRs are shown in Figure S6.
Flow Cytometry
All sorts and analysis were performed in a MoFlo three-laser flow cytometer
(DAKO Cytomation) and a LSR Fortessa (BD Biosciences), respectively. Spe-
cific details about flow cytometry protocols are given in the Supplemental
Experimental Procedures.
Western Blot
Whole-cell protein extracts were obtained from HUVEC cell line, cultured dur-
ing 3 days in hypoxic conditions (3%O2) in EC basal medium-2 (EBM-2, Lonza)
for EPO protein detection. Specific details about the western blot protocol are
given in the Supplemental Experimental Procedures.
Statistics
Analyses of significant differences between means were carried out using the
unpaired or paired two-tailed Student’s t test. Newman-Keuls post hoc or
Tukey’s multiple comparison tests were used whenever a significant differ-
ence between three or more sample means was revealed by a one-way
ANOVA. Tukey or Newman-Keuls test was used depending upon whether or
not additional power is required to detect significant differences between
means. p values %0.05 were considered significant. More details about the
statistical analysis are given in the Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2017.03.065.
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